FDA approves first gene therapy for genetic hearing loss
NBC News
—
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss
Regeneron inks drug price deal
- Trump promotes new drug price deal with Regeneron UPI —
- WATCH: Trump unveils deal with Regeneron to lower its drug prices for Medicaid PBS —
- Trump announces Regeneron deal to lower drug prices 📹 C-SPAN —
- Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free CNBC —
- Regeneron Shares Up on Trump Drug Pricing Deal Barrons —